Biopharm Asia, Inc. (1080908) SEC Filing 8-K Material Event for the period ending Monday, February 14, 2011

Biopharm Asia, Inc.

CIK: 1080908

View differences made from one to another to evaluate Biopharm Asia, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Biopharm Asia, Inc..


Assess how Biopharm Asia, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Biopharm Asia, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2011 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
CIK: 1080908
Form Type: 8-K Corporate News
Accession Number: 0001193805-11-000303
Submitted to the SEC: Mon Feb 14 2011 7:04:24 PM EST
Accepted by the SEC: Mon Feb 14 2011
Period: Monday, February 14, 2011
Industry: Pharmaceutical Preparations
  1. Accountant Change

External Resources:

Bookmark the Permalink: